US FDA approves Zydelig for three types of blood cancers
The US Food and Drug Administration has approved Zydelig (idelalisib) to treat patients with three types of blood cancers
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark’s consolidated revenue increases by 20.08 per cent
Consolidated net profit increases by 43.65 per cent
GVK BIO launches brand CLINOGENT
To offer bioequivalence studies for generic pharma and late phase patient-based clinical studies for research-based companies
IPM garners Rs 6636 crores in June
The Mumbai market grew the highest at 24.3 per cent followed by Vidarbha at 21.3 per cent
DIA to organise 9th Annual India Conference
It will be held in Mumbai from October 16-18, 2014; the theme for the event will be ‘The Future of Indian Healthcare: Patients,…
IDMA’s writ petition results in relief for the nutra sector
IDMA briefing on impact of Mumbai HC order quashing FSSAI advisory
IPA sends charter of demands to Health Minister to pharmacists
Include minimum pay equivalent to primary teacher or junior engineer
Dr Reddy’s posts consolidated revenues at Rs 35.2 billion for quarter ended June 30, 2014
The company has posted profit after tax at Rs 5.5 billion
Cipla partners with BioQuiddity
To launch the CE Marked OneDose ReadyfusOR pre-filled with Ropivacaine under its own label into the German market late this year
India’s loss, China’s gain?
India's drug pricing authority, the National Pharmaceutical Pricing Authority is once again at loggerheads with the industry